# Xofigo

NDC: 50419-208
Generic name: Radium Ra 223 dichloride
Labeler / Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20130520

FDA application: NDA203971

## Active ingredients

- RADIUM RA-223 DICHLORIDE: 30 uCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50419-208"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50419-208
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a398400e-bd31-41a9-9696-4f7c06569ede